“The industry needs a 360-degree assessment of the performance, drivers, motivations, hesitations, and leading edge techniques of patients, investigators, pharmaceutical companies, and pharmaceutical service organizations. Delays in patient recruitment not only have monetary impacts, but they have patient well-being impacts as well.”
View File